CellaVision AB financials
CellaVision AB
529900IUBZBZ0HXFJ114 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 723.2M | SEK 677.3M |
| Cost of sales | SEK 236.1M | SEK 214.3M |
| Gross profit | SEK 487.1M | SEK 463.0M |
| Administrative expenses | SEK 85.4M | SEK 76.0M |
| Operating profit (EBIT) | SEK 177.7M | SEK 167.1M |
| Profit before tax | SEK 176.9M | SEK 164.2M |
| Income tax expense | SEK 36.1M | SEK 33.9M |
| Profit for the year | SEK 140.7M | SEK 130.3M |
| Total comprehensive income | SEK 153.0M | SEK 128.4M |
| Per share | ||
| Basic EPS | SEK 5.90 | SEK 5.46 |
| Diluted EPS | SEK 5.90 | SEK 5.46 |
| Free cash flow / share | SEK 7.82 | SEK 6.90 |
| Cash flow statement | ||
| Net cash from operating activities | SEK 198.4M | SEK 196.4M |
| Income taxes paid | SEK 26.2M | SEK 27.6M |
| Net cash from investing activities | -SEK 76.0M | -SEK 85.5M |
| Purchase of PP&E (capex) | SEK 12.0M | SEK 31.8M |
| Net cash from financing activities | -SEK 95.1M | -SEK 97.0M |
| Dividends paid | SEK 53.7M | SEK 53.7M |
| Repayments of borrowings | SEK 29.0M | SEK 31.4M |
| Lease liability payments | SEK 12.5M | SEK 11.9M |
| Net change in cash | SEK 27.3M | SEK 13.9M |
| Balance sheet | ||
| Total assets | SEK 1.01B | SEK 928.7M |
| Non-current assets | SEK 610.2M | SEK 563.1M |
| Intangible assets & goodwill | SEK 128.1M | SEK 123.8M |
| Current assets | SEK 402.8M | SEK 365.6M |
| Inventories | SEK 124.8M | SEK 126.0M |
| Trade & other receivables | SEK 102.8M | SEK 97.8M |
| Cash & equivalents | SEK 149.4M | SEK 121.6M |
| Total equity | SEK 815.7M | SEK 716.4M |
| — attributable to owners | SEK 815.7M | SEK 716.4M |
| Non-current liabilities | SEK 88.2M | SEK 93.2M |
| Long-term borrowings | SEK 12.7M | SEK 28.7M |
| Current liabilities | SEK 109.1M | SEK 119.2M |
| Short-term borrowings | SEK 14.2M | SEK 36.0M |
| Deferred tax liabilities | SEK 69.3M | SEK 59.6M |
| Derived metrics | ||
| Free cash flow | SEK 186.4M | SEK 164.7M |
| Operating margin | 24.6% | 24.7% |
| Net margin | 19.5% | 19.2% |
| Return on equity | 17.3% | 18.2% |
| Cash conversion ratio | 1.41× | 1.51× |
| Capex coverage | 16.54× | 6.18× |
| Other reported items | ||
| Additional Paidin Capital | SEK 10.8M | SEK 10.8M |
| Adjustments For Decrease Increase In Inventories | -SEK 1.7M | SEK 12.6M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -SEK 15.8M | SEK 7.3M |
| Adjustments For Increase Decrease In Trade and Other Payables | SEK 2.1M | -SEK 9.5M |
| Cash Flows From Used In Operations Before Changes In Working Capital | SEK 213.8M | SEK 186.0M |
| Current Accruals and Current Deferred Income Including Current Contract Liabilities | SEK 58.1M | SEK 45.5M |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | SEK 7.1M | SEK 8.1M |
| Current Tax Assets Current | SEK 3.3M | SEK 5.8M |
| Current Tax Liabilities Current | SEK 0 | SEK 651.0K |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | SEK 59.6M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | SEK 2.50 | SEK 2.25 |
| Dividends Recognised As Distributions To Owners of Parent | SEK 53.7M | SEK 53.7M |
| Dividends Recognised As Distributions To Owners Per Share | SEK 2.25 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | SEK 443.0K | -SEK 275.0K |
| Equity and Liabilities | SEK 1.01B | SEK 928.7M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | SEK 37.0K | SEK 32.0K |
| Increase Decrease In Working Capital | SEK 15.4M | -SEK 10.4M |
| Intangible Assets Under Development | SEK 268.0M | SEK 209.9M |
| Interest Paid Classified As Operating Activities | SEK 1.9M | SEK 3.3M |
| Interest Received Classified As Operating Activities | SEK 2.1M | SEK 898.0K |
| Issued Capital | SEK 3.6M | SEK 3.6M |
| Land and Buildings | SEK 88.1M | SEK 95.3M |
| Noncurrent Financial Assets | SEK 2.7M | SEK 4.4M |
| Noncurrent Provisions | SEK 6.3M | SEK 4.9M |
| Number of Shares Outstanding | 23.9M | 23.9M |
| Other Adjustments For Noncash Items | SEK 63.1M | SEK 49.4M |
| Other Comprehensive Income | SEK 12.3M | -SEK 1.9M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | SEK 12.2M | -SEK 2.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | SEK 150.0K | SEK 133.0K |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | SEK 12.2M | -SEK 2.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | SEK 112.0K | SEK 101.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | SEK 12.2M | -SEK 2.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | SEK 112.0K | SEK 101.0K |
| Other Current Payables | SEK 2.4M | SEK 2.5M |
| Other Current Receivables | SEK 15.4M | SEK 6.3M |
| Other Reserves | SEK 29.7M | SEK 17.5M |
| Payments For Development Project Expenditure | SEK 65.8M | SEK 54.7M |
| Purchase of Investments Other Than Investments Accounted For Using Equity Method | -SEK 1.7M | -SEK 944.0K |
| Research and Development Expense | SEK 87.4M | SEK 83.3M |
| Retained Earnings | SEK 771.6M | SEK 684.6M |
| Selling Expense | SEK 136.6M | SEK 136.6M |
| Shortterm Warranty Provision | SEK 2.3M | SEK 2.0M |
| Trade and Other Current Payables To Trade Suppliers | SEK 32.2M | SEK 32.5M |
| Weighted Average Shares | 23.9M | 23.9M |
Every line item above is a fact tagged in CellaVision AB's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (SEK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.